🇺🇸 FDA
Patent

US 9909122

Compositions and methods of nucleic acid-targeting nucleic acids

granted A61KA61K38/465A61K47/549

Quick answer

US patent 9909122 (Compositions and methods of nucleic acid-targeting nucleic acids) held by Caribou Biosciences, Inc. expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Caribou Biosciences, Inc.
Grant date
Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/465, A61K47/549, A61K47/6455, A61P